Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
I am looking for
added new label for I am looking for
Advanced Filters
Found 95 clinical trials
A Study Extension Period of PEG-somatropin (Pegylated-somatropin) in the Treatment of Children With Idiopathic Short Stature

After the first stage (52 weeks) of Phase II clinical trial, Pegylated recombinant human growth hormone (PEG-rhGH) injection of appropriate dose in compliance with ISS clinical treatment

growth hormone
  • 25 Feb, 2022
  • 6 locations
The Effect of Nutritional Formula Supplementation on Linear Growth of Growth Hormone (GH) Treated Prepubertal Children With Idiopathic Short Stature (ISS) After 2 Years From the Beginning of GH-therapy

The proposed study is a double blind, randomized, placebo controlled study. The aim of the study is to evaluate the effect of combined growth hormone (GH) treatment &nutritional formula

  • 09 Apr, 2023
  • 1 location
A Randomized Control Trial to Investigate the Effect of Growth Hormone on the Euploid Rate of Blastocyst in Patients With Advanced Maternal Age

randomised into one of the two groups: Treatment group: Women will receive growth hormone (GH) supplement before and during antagonist protocol for ovarian stimulation. Control group: Women

  • 28 Oct, 2022
  • 1 location
Safety and Efficacy of Pegvisomant in Children With Growth Hormone Excess

Background For children with gigantism, too much growth hormone (GH) in the body causes abnormal growth and many other problems. Current treatments often don t

growth hormone
hand x-ray
pituitary tumor
medical therapy
  • 25 Aug, 2023
  • 1 location
Study of Growth Hormone Inhibition Using Pegvisomant in Severe Insulin Resistance

> To learn if blocking the effects of growth hormone in the body will help people with severe insulin resistance. Eligibility Adults aged 18 to 65 years with

  • 17 Sep, 2023
  • 1 location
A Controlled Trial of Growth Hormone in Phelan-McDermid Syndrome and Idiopathic Autism

This clinical trial will use growth hormone as a novel treatment for Phelan-McDermid syndrome (PMS) and idiopathic autism. A double-blind, placebo-controlled crossover trial design will be used

  • 04 Oct, 2022
Growth Hormone Releasing Hormone Analog to Improve Nonalcoholic Fatty Liver Disease and Associated Cardiovascular Risk

. Growth hormone is a hormone produced in the pituitary gland that helps regulate metabolism and growth. Individuals with obesity, on average, secrete less growth hormone than individuals without obesity

hepatic failure
vitamin e
proton magnetic resonance spectroscopy
  • 04 Oct, 2022
A Trial to Investigate Different Doses of Lonapegsomatropin Compared to Somatropin in Individuals With Turner Syndrome

A 104 week dose finding open label trial of lonapegsomatropin, a long-acting growth hormone product, administered once-a-week versus daily somatropin product in prepubertal individuals with

  • 18 Sep, 2023
  • 9 locations
A Randomized Controlled Trial of Growth Hormone to Improve the Clinical Outcome of Assisted Fertility in Young Patients With Decreased Ovarian Reserve

. Group A was the experimental group, which was treated with growth hormone for 3 months (2 units per day) before IVF/ICSI. Group B was the control group, which was directly assisted by IVF/ICSI.

  • 27 Oct, 2022
  • 1 location
Evaluating the Impact of Focused Muscle Contraction Therapy in U.S. Veterans

This research study is being done to investigate if the GH Method exercise program positively affects body composition, improves physical abilities and can improve the overall sense of wellbeing

symptoms of stress
depressed mood
  • 31 Oct, 2021
  • 1 location